Reportstack is one of the largest online libraries of market research publications. We are the fastest growing and most preferred provider of business intelligence in the market today. We partner with the world's top publishers and research houses to bring to you expert analysis, accurate data and market information along with the best customer support and user experience. For more details, please visit www.reportstack.com
Friday, 26 May 2017
Detailed Study of the Enteral Stents Market in Europe
MediPoint: Enteral Stents - Europe Forecast and Market Analysis is a new market research publication announced by Reportstack. Enteral stents are a palliative treatment option for constrictions caused primarily by various cancers. The primary cancers which cause constrictions requiring the use of enteral stents are esophageal cancer, gastric cancer, pancreatic cancer, and colorectal cancer.
There are three primary enteral stents; the covered enteral stent, the partially covered enteral stents, and the non-covered enteral stent. The market is led by three key players. The market will continue to grow as cancer prevalence increases and patients become more familiar with enteral stenting as a treatment option.
This report examines the enteral stents market in 21 major European markets: Austria, Belgium, Czech Republic, Denmark, Finland, France, Greece, Germany, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Russia, Spain, Sweden, Switzerland, Turkey and the UK.
This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed products, current players, as well as market outlooks in the European market.